OMX Copenhagen PI 1255369 / DK0060488385
1’493.52
Pkt
-8.58
Pkt
-0.57
%
17:00:14
Anzeige
Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
---|---|---|---|---|---|
Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | |
Marktkapitalisierung |
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Copenhagen PI-Werten
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
04.11.24 | Novo Nordisk Neutral | UBS AG | |
04.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
31.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
31.10.24 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.10.24 | Novo Nordisk Neutral | UBS AG | |
22.10.24 | Novo Nordisk Halten | DZ BANK | |
21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.10.24 | Novo Nordisk Underperform | Bernstein Research | |
17.10.24 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
15.10.24 | Novo Nordisk Neutral | UBS AG | |
10.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
03.10.24 | Novo Nordisk Neutral | UBS AG | |
27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.09.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
20.09.24 | Novo Nordisk Neutral | UBS AG | |
12.09.24 | Novo Nordisk Buy | Deutsche Bank AG | |
11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
11.09.24 | Novo Nordisk Neutral | UBS AG | |
10.09.24 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
06.09.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
09.08.24 | Novo Nordisk Neutral | UBS AG | |
08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
08.08.24 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
07.08.24 | Novo Nordisk Neutral | UBS AG | |
07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
07.08.24 | A.P. Moeller - Maersk A-S Neutral | Goldman Sachs Group Inc. | |
07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.08.24 | Novo Nordisk Neutral | UBS AG | |
31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. |